Pharmakotherapeutische Probleme beim betagten Patienten

  • F. Anschütz
  • F. Krück
  • H. Kreuzer
  • E. Ritz
  • G. Schettler
  • H. Greten
  • K. Seige
  • J. Köbberling
  • P. Wichert
  • S. Kanowski
  • P. W. Hartl
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für innere Medizin book series (VDGINNERE, volume 91)

Zusammenfassung

Die Begründung des Tagesthemas liegt in der Problematik der Pharmakotherapie bei Multimorbidität des Betagten und der dadurch verordneten großen Anzahl von Medikamenten. So müßte ein 70jähriger Patient mit Hochdruck, Diabetes, Belastungsinsuffizienz, Leberzirrhose und Hyperlipidaemie, eigentlich 16 Tabletten einnehmen. Mit dieser Zahl aber steigen erwiesenermaßen Nebenwirkungen, Interaktionen und die Non-Compliance.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Edelman IS, Leibman J (1959) Anatomy of body water and electrolytes. Amer J Med 27: 256–277PubMedGoogle Scholar
  2. Leaf A (1985) Special hazards in the volume depleted elderly. In: Butler RN, Beam AG (ed) The aging process. Raven Press, New York, pp 193–205Google Scholar
  3. McLachlan MSF (1978) The aging kidney. Lancet II: 143–146Google Scholar
  4. Mildvan AS, Strehler BL (1960) A critique of the theories of mortality. In: Strehler BL (ed) Biology of aging. Amer Institute of Biological SciencesGoogle Scholar
  5. Phillips PA, Rolls BJ, Ledingham JGG, Forsling ML, Morton JJ, Crowe MJ, Wollner L (1984) Reduced thirst after water deprivation in healthy elderly men. New Engl J Med 311: 753–759PubMedGoogle Scholar
  6. 1.
    Onesti G, Kim KE (eds) (1981) Hypertension in the young and the old. (The sixth Hahnemann international symposium on hypertension), Grune & Stratton, New YorkGoogle Scholar
  7. 2.
    Platt D (ed) (1983) Cardiology and ageing. Schattauer, StuttgartGoogle Scholar
  8. 3.
    Bergener M, Grobecker H (Hrsg) (1984) Hypertonie im Alter: Normvariante oder Krankheit. Schattauer, StuttgartGoogle Scholar
  9. 4.
    Zanchetti A, Leonetti G (1984) Hypertension in the elderly: Special considerations. In: Butler RN, Beam AG (eds) The aging Process: Therapeutic implications. Raven Press, New York, pp 175–189Google Scholar
  10. 5.
    Ritz E (1985) Hypertonie im Alter. In: Ganten D, Ritz E (Hrsg) Hypertonie — ein Lehrbuch. Schattauer, Stuttgart, S 350–357Google Scholar
  11. 6.
    Miall WE, Oldham PD (1963) The hereditary factor in arterial blood pressure. Br Med J 1: 75–77PubMedGoogle Scholar
  12. 7.
    Stieber J, Döring A, Keil U (1982) Häufigkeit, Bekanntheits-und Behandlungsgrad der Hypertonie in einer Großstadtbevölkerung. Mchn Med Wschr 124: 747–752Google Scholar
  13. 8.
    Miall WE, Brennan PJ (1981) Hypertension in the elderly: The South Wales study. In: Onesti G, Kim KE (eds) Hypertension in the young and the old. Grune and Stratton, New York, pp 277–283Google Scholar
  14. 9.
    Kannel WB (1981) Implications of Framingham study data for treatment of hypertension: impact of other risk factors. In: Laragh JH, Bühler FR, Seldin DW (eds) Frontiers in Hypertension Research. Springer, New York, pp 17–23Google Scholar
  15. 10.
    Harris T, Cook E, Kannel W, Schatzkin A, Goldman L (1985) Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 7: 118–124PubMedGoogle Scholar
  16. 11.
    Forette F, de la Fuente X, Golmard JL, Henry JF, Hervy MP (1982) The prognostic significance of isolated systolic hypertension in the elderly: results of a ten year longitudinal study. Clin Exp Hypertens 4: 1177–1191Google Scholar
  17. 12.
    Kannel WB (1984) Hypertensive Disease in the elderly: A consequence of Arteriosclerosis or blood pressure. In: Bergener M, Grobecker H (Hrsg) Hypertonie im Alter: Normvariante oder Krankheit? Schattauer, S 31–48Google Scholar
  18. 13.
    Terasawa F, Kuramoto K, Ying LH, Suzuki T, Kuramochi M (1972) The study on the hemodynamics in old hypertensive subjects. Acta Gerontol Jpn 56: 47Google Scholar
  19. 14.
    Goldstein DS (1981) Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension 3: 48–52PubMedGoogle Scholar
  20. 15.
    Bühler FR, Kiowski W, Landmann R, Van Brummelen P, Amann W, Bolli P, Bertel O (1981) Changing role of beta and alpha-adrenoceptor-mediated cardiovascular responses in the transition from high-cardiac output into a high-peripheral resistance phase in essential hypertension. In: Laragh JH, Bühler FR, Seldin DW (eds) Frontiers in Hypertension Research. Springer, New York, pp 316–324Google Scholar
  21. 16.
    O’Hara N, Daul AE, Fesel R, Siekmann U, Brodde O-E (1985) Different mechanisms underlying reduced beta2 adrenoreceptor responsiveness in lymphocytes from neonates and old subjects. Mech Ageing Develop (in press)Google Scholar
  22. 17.
    Brodde O-E, Anlauf M, Graben N, Bock KD (1982) Age-dependent decrease of alpha-2-adrenergic receptor number in human platelets. Europ J Pharmacol 81: 345–348Google Scholar
  23. 18.
    Shimada K, Kitazumi T, Sadakane N, Ogura H, Ozawa T (1985) Age-related changes of baroreflex function, plasma norepinephrine and blood pressure. Hypertension 7: 113–117PubMedGoogle Scholar
  24. 19.
    Weidmann P (1980) Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus. Klin Wschr 58: 1071–1091PubMedGoogle Scholar
  25. 20.
    Cole F, Blakesley H, Graci K, Frohlich E, Mac Phee A (1980) Brain angiotensin II receptor affinity and capacity in SHR and WKY rats. Effects of acute dietary changes in NaCl. Brain Res 190: 272–277Google Scholar
  26. 21.
    Lindemann R, Tobin J, Shock NW (1984) Association between blood pressure and the rate of decline in renal function with age. Kidney Intern 26: 861–868Google Scholar
  27. 22.
    Ritz E (1983) Rolle der Niere and der Elektrolyte in der Hochdruckpathogenese. Therapiewoche 33: 1813–1824Google Scholar
  28. 23.
    Lever A, Beretta-Piccoli C, Brown J, Davies D, Fraser R, Robertson J (1981) Sodium and potassium in essential hypertension. Brit Med J 283: 463–468Google Scholar
  29. 24.
    Castleden CM, George CF (1979) The effect of ageing on the hepatic clearance of propranolol. Brit J Clin Pharmacol 7: 49–54Google Scholar
  30. 25.
    Kelly JG, McGarry K, O’Malley K, O’Brien ET (1982) Bioavailability of labetalol increases with age. Br J Clin Pharmac 14: 304–305Google Scholar
  31. 26.
    Norbury HM, Franklin RA, Marrot PK, Warrington SJ (1984) Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers. Eur J Clin Pharmacol 27: 247–249PubMedGoogle Scholar
  32. 27.
    Andreasen F, Hansen U, Husted SE, Jansen JA (1983) The pharmacokinetics of frusemide are influenced by age. Br J Clin Pharmac 16: 391–397Google Scholar
  33. 28.
    Möhrke W, Mutschler E, Völger K-D, Mühlberg W, Platt D. Triamterene kinetics in the higher age. In: Platt D (ed) Cardiology and ageing. Schattauer, Stuttgart, pp 367–377Google Scholar
  34. 29.
    Kerremans ALM, Tan Y, von Baars H, von Ginneken CAM, Gribnan FWJ (1983) Furosemide kinetics and dynamics in aged patients. Clin Pharmacol Ther 34: 181–189PubMedGoogle Scholar
  35. 30.
    Veterans administration cooperative study group (1982) Low doses and standard dose of Reserpine a randomized, double-blind, multiclinic trial in patients taking Chlortalidone. Jama 248: 2471–2477Google Scholar
  36. 31.
    Mater-son (1978) Dose response to chiortalidone in patients with mild hypertension — efficacy of a lower dose. Clin Pharm Ther 24: 192Google Scholar
  37. 32.
    Veterans Administration cooperative study group on antihypertensive agents (1972) Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure and poor cardiovascular disease, further analysis of side effects. Circulation 45: 991–1004Google Scholar
  38. 33.
    The Management Committee (1981) Treatment of mild hypertension in the elderly. A study initiated and administrated by the National Heart Foundation of Australia. Med J Aus 2: 398–402Google Scholar
  39. 34.
    Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. 1. Reduction in mortality of persons with high blood pressure including mild hypertension. Jama 242: 2562–2571Google Scholar
  40. 35.
    The Management Committee (1979) The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267Google Scholar
  41. 36.
    The European Working Party on High Blood Pressure in the Elderly (EWPHBPE) (1984) Antihypertensive therapy in elderly patients. Ninth Interim Report. Neth J Med 27: 165–170Google Scholar
  42. 37.
    Bühler FR (1983) Age and cardiovascular response adaption. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium-entry blockers. In: Tarazi RC, Zanchetti A (eds) Response to antihypertensive treatment. Hypertension 5 (Suppl III):III.94—III. 100Google Scholar
  43. 38.
    MacGregor GA, Rotallar C, Markandu ND, Smith SJ, Sagnella GA (1982) Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 4 (Suppl 3): 358–362Google Scholar
  44. 39.
    Wikstrand J, Berglund G (1982) Antihypertensive treatment with beta-blockers in patients aged over 65. Br Med J 285: 850Google Scholar
  45. 40.
    Tourkantonis A, Lasaridis A, Settas L (1984) Clinical Experience with long-term Nitrendipine treatment in essential hypertension. J Cardiovasc Pharmacol 6: 1090–1095Google Scholar
  46. Franke H (1984) Wesen und Bedeutung der Polypathie und Multimorbidität in der Altersheilkunde. Internist 25: 451–455PubMedGoogle Scholar
  47. Kanowski S. Ist Altern heilbar — oder vom Nutzen sogenannter Geriatrika. (Persönlicher Bericht)Google Scholar
  48. Lehr U (1982) Langlebigkeit — nicht allein eine Frage der Medizin. Sandorama 5: 14–17Google Scholar
  49. Michael D (1984) Zur Biorheuse des kardiovaskulären Systems und ihren therapeutischen Konsequenzen. Internist 25: 478–484Google Scholar
  50. Multiple Risk Factor Intervention Trial Research Group: MRFIT (1982) JAMA 248:1465–1477Google Scholar
  51. Schettler G (1984) Prävention und Regression der Arteriosklerose. Inn Med 11: 87–92Google Scholar
  52. Schettler G (1984) Der Mensch ist so jung wie seine Gefäße. (Ed: Schettler G) 3. Aufl. Piper, München ZürichGoogle Scholar
  53. Schettler G (1984) Primäre und Sekundäre Prävention der Koronaren Herzkrankheiten: Empfehlungen der Titisee-Konferenz der Internationalen Society and Federation of Cardiology (WHO). Dtsch Ärztebl 81: 7Google Scholar
  54. Schettler G (1985) Gangarten der Arteriosklerose. Ref. gehalten anl. des Geburtstags-Symposiums von W. Doerr Heidelberg (im Druck) — The Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results (1984) JAMA 251: 351–374Google Scholar
  55. World Health Organization (WHO) Geneva (1982) Report of a WHO Expert Committee: Prevention of Coronary Heart Disease. Technical Report Series 678.Google Scholar
  56. 1.
    Dietary and Pharmacologic Therapy for the Lipid Risk Factors. Jama 250: 1873–1879 (1983)Google Scholar
  57. 1.
    Statistisches Jahrbuch der DDR 1983, 28. Aufl. Staatsverlag der DDR, Berlin, S 400Google Scholar
  58. 2.
    Seige K (1959) Zur sozialmedizinischen Bedeutung des Diabetes mellitus. In: Oberdisse K, Jahnke K (eds) Diabetes mellitus. Thieme, Stuttgart, S 681–688Google Scholar
  59. 3.
    Seige K (1967) Diabetes mellitus. 2. Aufl., VEB Thieme, Leipzig, S 79–82Google Scholar
  60. 4.
    Spuck W (1984) Intensivierte Diabetestherapie. Internist 25: 741–746PubMedGoogle Scholar
  61. 5.
    Müller G (1983) Klinische Biochemie. 2. Aufl., VEB Fischer, Jena, S 230Google Scholar
  62. 6.
    Jahnke K (1981) Behandlung des Erwachsenendiabetes (Typ II). In: Schlegel B (Hrsg) Verhandl Dtsch Ges Inner Med 87: 25–34Google Scholar
  63. 7.
    Robbers H, Sauer H, Willms B (1981) Praktische Diabetologie. 2. Aufl., Banaschewski, München/Gräfelfing, S 132–135, 144Google Scholar
  64. 8.
    Schmidt FH (1983) Pharmakokinetik von Tolbutamid und Glibenclamid und ihre Veränderungen bei Niereninsuffizienz. Dtsch Diabetes Ges, Göttingen, 12.-14. MaiGoogle Scholar
  65. 9.
    Mehnert K, Schöffling K (1984) Diabetologie in Klinik und Praxis. 2. Aufl., Thieme, Stuttgart New York, S 220–239Google Scholar
  66. 10.
    Bibergeil H (1974) Diabetes mellitus. VEB Fischer, Jena, S 177–294Google Scholar
  67. 11.
    Pfeiffer EF, Kerner W (1984) Diabetestherapie: Künstliches endokrines Pankreas und tragbare Insulinpumpen. Dtsch Ärzteblatt 81: 1–9Google Scholar
  68. 12.
    Mohnike G (1963) Diagnose und Behandlung diabetischer Blutgefäßkomplikationen. internist prax 3: 99–112Google Scholar
  69. 13.
    Bürger M (1954) Angiopathia diabetica. Thieme, StuttgartGoogle Scholar
  70. 14.
    Bürger M (1960) Altern und Krankheit als Problem der Biomorphose. 4. Aufl., VEB Thieme, LeipzigGoogle Scholar
  71. 15.
    Sternitzky R, Seige K (1983) Hämorheologische Veränderungen und ihre Bedeutung bei chronisch-arterieller Verschlußkrankheit. Z inner Med 38: 1–7Google Scholar
  72. 16.
    Federlin K (1981) Zukunftsaussichten der Diabetestherapie. In: Schlegel B (Hrsg) Verhandl Dtsch Ges Inner Med 82:34–48 — 17. Katsch G (1938) Grazer Thesen. Klin Wochenschr 16: 399Google Scholar
  73. 1.
    Bell GM, Todd WTA, Forfar JC, Martyn C, Wathen CG, Gow S, Riemersma R, Toft AD (1985) End-organ response to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol 22: 83–89Google Scholar
  74. 2.
    Caplan RH, Wickus G, Glasser JE, Davis K, Wahner HW (1981) Serum concentrations of the iodothyronines in elderly subjects: decreased triiodothyronine (T3) and free T3 index. J Amer Geriatrics Soc 24: 19–24Google Scholar
  75. 3.
    Harman SM, Wehmann RE, Blackman MR (1984) Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusions to thyrotropin releasing hormone. J Clin Endocrinol Metab 58: 320–326PubMedGoogle Scholar
  76. 4.
    Herrmann J (1981) Prevalence of hypothyroidism in the elderly in Germany. A pilot study. J Endocrinol Invest 4: 327–330PubMedGoogle Scholar
  77. 5.
    Herrmann J (1982) Altersabhängigkeit von Schilddrüsenparametern. Akt Endokr Stoffw 3: 38–41Google Scholar
  78. 6.
    Herrmann J, Emrich D, Kemper F, Köbberling J, Pickardt RC, Stubbe P (1984) Jodexceß und seine Auswirkungen. Dtsch Med Wochenschr 109: 1077–1080PubMedGoogle Scholar
  79. 7.
    Herrmann J, Heinen E, Kröll KJ, Rudolf KH, Krüskemper HL (1981) Thyroid function and thyroid hormone metabolism in elderly people. Low T3-syndrome in old age? Klin Wochenschr 59: 315–323PubMedGoogle Scholar
  80. 8.
    Hintze G (1981) Diagnostik, Klinik und Prognose der Hyperthyreose im höheren Lebensalter. Med Diss (Göttingen )Google Scholar
  81. 9.
    Hintze G, Dirks H, Becker HD, Köbberling J (1983) Die subtotale Thyreoidektomie bei jodinduzierter Hyperthyreose. Verh Dtsch Ges Inn Med 89: 1061–1064Google Scholar
  82. 10.
    Horster FA, Klusmann G, Wildmeister W (1975) Der Kropf: eine endemische Krankheit in der Bundesrepublik? Dtsch Med Wochenschr 100: 7–8Google Scholar
  83. 11.
    Klingler W, Vierke G, Ball P (1982) Die Serumkonzentration des freien Thyroxins in Abhängigkeit vom Lebensalter. NucCompact 13: 74–76Google Scholar
  84. 12.
    Köbberling J, Hintze G (1983) Spezielle Probleme der Hyperthyreose bei alten und schwerkranken Patienten. Internist 24: 453–459PubMedGoogle Scholar
  85. 13.
    Köbberling J, Hintze G, Becker HD (1985) Iodine-induced thyrotoxicoses — A case for subtotal thyroidectomy in severely ill patients. Klin Wochenschr 63: 1–7PubMedGoogle Scholar
  86. 14.
    Kojima N, Sakata S, Nakamura S, Kamikubo K, Okuyama M, Miura K (1983) Age-and sex-related differences of serum thyroxine binding globulin ( TBG) in healthy subjects. Acta endocr 104: 303–306Google Scholar
  87. 15.
    Nishikawa M, Inada M, Naito K, Ishii H, Tanaka K, Mashio Y, Imura H (1981) Age-related changes of serum 3,3’-diiodothyronine, 3’,5’-diiodothyronine, and 3,5-diodothyronine concentrations in man. J Clin Endocrinol Metab 52: 517–521PubMedGoogle Scholar
  88. 16.
    Pickardt CR (1983) Schilddrüsenfunktionsänderungen unter antiarrhythmischer Therapie mit Amiodaron. Dtsch Med Wochenschr 108: 1856–1866PubMedGoogle Scholar
  89. 17.
    Rosenbaum RL, Barzel US (1982) Levothyroxine replacement dose for primary hypothyroidism decreases with age. Annals Int Med 96: 53–55Google Scholar
  90. 18.
    Rudorff KH, Herrmann J, Krüskemper HL (1981) Altersabhängige Änderung von In-vitro-Parametern für die Schilddrüsendiagnostik. Internistische Welt 3: 102–108Google Scholar
  91. 19.
    Sawin CT, Herman T, Molitch ME, London MH, Kramer SM (1983) Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 75: 206–209Google Scholar
  92. 20.
    Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie (1985) Schilddrüsenfunktionsdiagnostik und die Diagnose von Schilddrüsenkrankheiten. Intern Welt 8:50–57 und 78–86Google Scholar
  93. 21.
    Szabolcs I, Szilagyi G, Irsy G, Kovacs ZS, Weber MN, Halasz T (1981) The suppressive effect of triiodothyronine on the release of thyrotropin in old age. Endokrinologie 78: 305–307PubMedGoogle Scholar
  94. 22.
    Wilke TJ (1983) Influence of age and sex on the concentration of free thyroxin in serum and on the free thyroxin: total thyroxin ratio. Clin Chem 29: 1428–1430PubMedGoogle Scholar
  95. 23.
    Yamada T, Naka M, Komiya I, Ichikawa K, Aizawa T, Hashizume K, Takasu N, Watanabe T (1984) Age-related alterations of pituitary-thyroid function in normal female subjects and in female patients with simple goitre. Acta endocr 107: 346–351PubMedGoogle Scholar
  96. 1.
    Antal, EJ, Kramer, PA, Mercik SA, Chapron DJ, Lawson IR (1981) Theophylline Pharmacokinetics in Advanced Age. Br J Clin Pharmac 12: 637Google Scholar
  97. 2.
    Arroyo J, Prywarra A, Daul A, Bock KD, Brodde OE (1982) Age-Dependant Decrease in the Number of Alpha, but not Beta-Adrenorecptors in Human Blood Cells. Therapiewoche 32: 5712Google Scholar
  98. 3.
    Bauer LA, Blouin RA (1981) Influence of Age on Theophylline Clearance in patients with chronic obstructive pulmonary disease. Clin Pharmacokinetics 6: 469Google Scholar
  99. 4.
    Cohen IA, Johnson CE, Berardi RR, Hyneck ML, Achem-Karem SR (1984) Effects of Age and Cimetidine Dose on the Magnitude of the Cimetidine-Theophylline Drug Interaction. Gastroenterol 86: 1050Google Scholar
  100. 5.
    Cotter TG, O’Malley K (1983) Decreased neutrophil cyclic AMP response to isoprenaline stimulation in the elderly. Clin Sci 65: 155PubMedGoogle Scholar
  101. 6.
    Davison W (1984) Adverse drug reactions in the elderly. In: Butler RN, Beam AG (eds) The aging process. Raven Press, New YorkGoogle Scholar
  102. 7.
    Dillon N, Chung S, Kelly J, O’Malley K (1980) Age and beta adrenoceptormediated function. Clin Pharmacol Ther: 769–8.Google Scholar
  103. 8.
    Doyle V, O’Malley K, Kelly JG (1982) Human lymphocyte ß-andrenoceptor density in relation to age and hypertension. J Cardiovas Pharmacology 4: 738Google Scholar
  104. 9.
    Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ (1984) Alterations in Leukocyte fl-Receptor Affinity with aging. New Engl J Med 310: 815PubMedGoogle Scholar
  105. 10.
    Ferlinz R (1983) Fortschritt und Fortbildung in der Medizin. Deutscher Arzteverlag, S 39Google Scholar
  106. 11.
    Fox RW, Samann S, Bukantz SC, Lockey RF (1983) Theophylline kinetics in a geriatric group. Clin Pharmacol Ther 34: 60PubMedGoogle Scholar
  107. 12.
    Fraser CM, Venter DC, Kalina M (1981) Autonomic abnormalities and autoantibodies to Beta-adrenergic Receptors. New Engl J Med 305: 1165Google Scholar
  108. 13.
    Galant SR, Duriseti L, Underwood S, Insel P (1978) Decreased beta adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. New Engl J Med 299: 933PubMedGoogle Scholar
  109. 14.
    Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors Affecting Theophylline Clearance: Age, Tobacco, Marijuana, Cirrhosis, Congestive Heart Failure, Obesity, Oral Contraceptives, Benzodiazepines, Barbiturates, and Ethanol. J Pharmaceutical Sci 68: 1358Google Scholar
  110. 15.
    Kendall MJ, Woods KL, Wilkins MR, Worthington DJ (1982) Responsiveness to ß-Adrenergic Receptor Stimulation: The Effects of Age are Cardioselective. Br J Clin Pharmacol 14: 821Google Scholar
  111. 16.
    Kelly J, O’Malley K (1984) Adrenoceptor function and ageing. Clin Science 66: 509Google Scholar
  112. 17.
    Krall JF, Connelly-Fittingoff M, Tuck ML (1983) Lymphocyte adenylate cyclase and Human aging. Proc Soc Exp Bio Med 173: 475Google Scholar
  113. 18.
    Lake CR, Ziegler MG, Coleman MG, Kopir IJ (1977) Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208PubMedGoogle Scholar
  114. 19.
    Lamy PP (1982) Comparative pharmacokinetic changes and drug therapy in an older population. J Amer Ger Soc 30: 11Google Scholar
  115. 20.
    Leaf A (1984) Special Hazards in the volume-depleted elderly. In: Butler RN, Beam AG (eds) The aging process. Raven Press, New YorkGoogle Scholar
  116. 21.
    Lemanske RF, Anderson C, Braun S, Skatrud, J, Busse WW (1980) Impaired in Vitro ß-Adrenergic Granulocyte Response in Chronic Obstructive Pulmonary Disease. Amer Rev Respir Dis 122: 213Google Scholar
  117. 22.
    Muittari A, Mattila MJ (1971) Bronchodilatator action of drug complications in asthmatic patients: ephedine. Theophylline and transquiling drugs. Curr Ther Res 13: 374PubMedGoogle Scholar
  118. 23.
    Podszus Th (1985) Unveröffentlichte BefundeGoogle Scholar
  119. 24.
    Rowe JW (1984) Physiologic changes with age and their clinical relevance. In: Butler RN, Beam AG (eds) The aging process. Raven Press, New YorkGoogle Scholar
  120. 25.
    Rowe JW (1985) Health care of the elderly. New Engl J Med 312: 827PubMedGoogle Scholar
  121. 26.
    Runge M, von Wiehert P (1985) Kardiale Therapie bei akuter Pneumonie. Prax Klin Pneumol 39Google Scholar
  122. 27.
    Schocken DD, Roth GS (1977) Reduced beta-adrenergic receptor concentration in aging mang. Nature 267: 856PubMedGoogle Scholar
  123. 28.
    Sever PS, Osikawa B, Birch M, Turnbridge RDG (1977) Plasma noradrenalin in essential hypertension. Lancet 1: 1078PubMedGoogle Scholar
  124. 29.
    Tsujimoto G, Hoffman BB (1983) Characterization of Beta Adrenergic Receptor in Mesenteric Artery: Absence of Age-Related Changes. Clin Res 31:21 AGoogle Scholar
  125. 30.
    Ulmer WT (1984) Lunge und Alter. Internist 25: 456PubMedGoogle Scholar
  126. 31.
    Vestal RF, Wood, AJ, Shand DG (1979) Reduced beta-adrenoceptor sensitivity in the Elderly. Clin Pharmacol Ther 26: 181PubMedGoogle Scholar
  127. 32.
    Vestal RF (1982) Pharmacology and aging. J Amer Ger Soc 30: 191Google Scholar
  128. 33.
    Weiss B, Greenberg L, Cantor E (1979) Age-related alterations in the development of adrenergic denervation supersensitivity. Fed Proc 38: 1915PubMedGoogle Scholar
  129. 34.
    von Wiehert P (1985) Pneumonien — Wandel eines Krankheitsbildes? Therapiewoche (im Druck)Google Scholar
  130. 35.
    Wissenschaftliches Institut der Ortskrankenkassen (WidO) Analyse von Struktur und Entwicklung der Arzneimittelausgaben der Krankenversicherung der Rentner. GKV Arzneimittelindex 1981Google Scholar

Weiterführende Literatur

  1. 1.
    Albanese A (1978) Calcium nutrition in the elderly. Postgrad Med 63: 167–172 (Mar)PubMedGoogle Scholar
  2. 2.
    Belcon MC, Haynes RB, Tugwell P (1984) A critical review of compliance studies in rheumatoid arthritis. Arthr Rheum 27: 1227–1233Google Scholar
  3. 3.
    Bland JH, Stulberg SD (1981) Osteoarthritis: Pathology and clinical patterns. In: Kelley WN, Harris Jr ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. WB Saunders Company, Philadelphia London Toronto, p 1472Google Scholar
  4. 4.
    Bluestone R (1982) The patient who hurts all over. Practical approach to diagnosis and management. Postgrad Med 72: 71–79 (Dec)PubMedGoogle Scholar
  5. 5.
    Brin M, Bauernfeind JC (1978) Vitamin needs of the elderly. Postgrad Med 63: 155–163 (Mar)PubMedGoogle Scholar
  6. 6.
    Busse EW (1978) How mind, body, and environment influence nutrition in the elderly. Postgrad Med 63: 118–125 (Mar)PubMedGoogle Scholar
  7. 7.
    Comfort A (1979) The myth of senility. Diagnosing nonspecific major illness in the elderly. Postgrad Med 65: 130–142 (Mar)PubMedGoogle Scholar
  8. 8.
    Editorial: Zur Behandlung älterer Patienten mit nichtsteroidalen Antirheumatika: Gibt es Unterschiede zu anderen Altersgruppen? Rheuma-Therapie aktuell 3:26–38 (1983); Altersbedingte Veränderungen der Kinetik von Wirkstoffen: Haben sie eine praktische Bedeutung? Rheuma-Therapie akutell 4:18 (1984); Geben ältere Patienten weniger häufig Nebenwirkungen an? Gezieltes Befragen ist notwendig. Rheuma-Therapie aktuell 4: 23 (1984)Google Scholar
  9. 9.
    Editorial: Medication for the elderly. A report of the Royal College of Physicians. J R Coll Physicians Lond 18: 7–17 (1984)Google Scholar
  10. 10.
    Editorial: Degenerative Gelenk-und Wirbelsäulenerkrankungen im Alter. Rheuma — Schmerz & Entzündung 4:12 (5/84)Google Scholar
  11. 11.
    Fleming ThC (1980) As our society ages. Postgrad Med 68: 19–20 (Oct)PubMedGoogle Scholar
  12. 12.
    Fleming ThC (1981) Aging — a woman’s issue. Postgrad Med 70: 13–14 (Nov)Google Scholar
  13. 13.
    Kolodny A, Klipper A (1984) Erkrankungen des Knochens und der Gelenke beim alten Menschen. Klinik Journal 4: 6–12Google Scholar
  14. 14.
    Krane StM, Holick MF (1983) Metabolic bone disease. Osteoporosis. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD (eds) Harrison’s principles of internal medicine, 10th edn. McGraw-Hill International Book Company, Auckland Bogota Guatemala Hamburg Johannesburg Lisbon London Madrid Mexico New Delhi Panama Paris San Juan Sao Paulo Singapore Sydney Tokyo, p 1949Google Scholar
  15. 15.
    Mallette LE (1982) Osteoporosis. Approaching treatment with optimism. Postgrad Med 72: 271–278 (Nov)PubMedGoogle Scholar
  16. 16.
    Morley JE (1983) The aging endocrine system. Evaluation and treatment of age-related disorders. Postgrad Med 73: 107–120 (Mar)PubMedGoogle Scholar
  17. 17.
    Reed K (1981) Tricyclic antidepressant blood levels. Eight practical questions. Postgrad Med 70: 81–88 (Nov)PubMedGoogle Scholar
  18. 18.
    Reutter FW (1983) Osteoporose. In: Krück F, Kaufmann W, Bünte H, Gladtke E, Tölle R (Hrsg) Therapie-Handbuch — Innere Medizin und Allgemeinmedizin. Urban & Schwarzenberg, München Wien Baltimore, S 1033Google Scholar
  19. 19.
    Schuster O, Kinetik in ihrer Beziehung zu Alter und Nebenwirkungen bei nichtsteroidalen Antirheumatika (persönliche Mitteilung)Google Scholar
  20. 20.
    Sivertson SE (1978) Common problems of ambulatory geriatric patients. A survey. Postgrad Med 64: 83–90 (Jul)PubMedGoogle Scholar
  21. 21.
    Sivertson SE, Knopke HJ, McDonald E (1980) Geriatrics in family practice. A comparison of data from Wisconsin and Virginia. Postgrad Med 68: 77–85 (Oct)PubMedGoogle Scholar
  22. 22.
    Weber JCP (1985) Epidemiologie der Nebenwirkungen nichtsteroidaler Antirheumatika. Klinikarzt 14:183–186, 209–212Google Scholar

Copyright information

© J. F. Bergmann Verlag, München 1985

Authors and Affiliations

  • F. Anschütz
    • 1
  • F. Krück
    • 2
  • H. Kreuzer
    • 3
  • E. Ritz
    • 4
  • G. Schettler
    • 5
  • H. Greten
    • 6
  • K. Seige
    • 7
  • J. Köbberling
    • 8
  • P. Wichert
    • 9
  • S. Kanowski
    • 10
  • P. W. Hartl
    • 11
  1. 1.Medizinische Klinik IStädtischen KlinikenDarmstadtDeutschland
  2. 2.Medizinische PoliklinikUniversität BonnDeutschland
  3. 3.GöttingenDeutschland
  4. 4.Medizinische Universitäts-Klinik (Ludolf-Krehl-Klinik)HeidelbergDeutschland
  5. 5.Klinikum der Universität HeidelbergDeutschland
  6. 6.Medizinische Kernklinik und PoliklinikUniversitäts-Krankenhaus EppendorfHamburgDeutschland
  7. 7.II. Medizinische Klinik und PoliklinikMartin-Luther-UniversitätHalle-WittenbergDeutschland
  8. 8.Medizinische UniversitätsklinikGöttingenDeutschland
  9. 9.Medizinische UniversitätspoliklinikMarburg/LahnDeutschland
  10. 10.BerlinDeutschland
  11. 11.Rheumaklinik AachenDeutschland

Personalised recommendations